Unknown OBSERVATIONAL NCT03571711

Meropenem Pharmacokinetics in Spontaneous Bacterial Peritonitis

Single- and Multiple-dose Pharmacokinetics of Meropenem in Spontaneous Bacterial Peritonitis and Liver Cirrhosis

Sponsor: Hannover Medical School

Conditions Liver Cirrhosis Peritonitis Bacterial

Updated 10 times since 2018 Last updated: Aug 6, 2019 Started: Jun 28, 2018 Primary completion: Jul 1, 2020 Completion: Jan 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Liver Cirrhosis and Peritonitis Bacterial, this trial is ongoing. The trial is conducted by Hannover Medical School and has accumulated 10 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Oct 2021 — Dec 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status

▶ Show 5 earlier versions

Jan 2021 — Oct 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
Sep 2019 — Nov 2020 [monthly]

Recruiting
Aug 2018 — Sep 2019 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jul 2018 — Aug 2018 [monthly]

Not Yet Recruiting

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hannover Medical School

Data source: Hannover Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hanover, Germany